メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
東北大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
馬場 啓聡
助教
大学病院・内科
h-index
109
被引用数
6
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2015
2022
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(24)
類似のプロファイル
(6)
Pureに変更を加えた場合、すぐここに表示されます。
フィンガープリント
Hiroaki Babaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Patient
100%
COVID-19
95%
Antibiotic Resistance
50%
Pneumonia
36%
Therapeutic Procedure
32%
River Water
27%
Rebound
25%
Listeriosis
25%
Tuberculosis
25%
Cytokinesis
25%
Haemophilus influenzae
25%
Syndrome
25%
Hospital
24%
Infection
24%
Serotype
22%
Carbapenem
21%
Case Report
19%
Listeria monocytogenes
18%
Bacterium
18%
Gene
18%
Analysis
18%
Antiinfective Agent
18%
Corticosteroid
17%
Influenza A Virus (H3N2)
16%
Chromobacterium
16%
near Drowning
16%
Pseudomonas aeruginosa
16%
Organism
16%
Combination Therapy
16%
Acute Respiratory Distress Syndrome
15%
Surveillance
14%
Vaccine
14%
Etoposide
13%
Lung
12%
Prevalence
12%
Enterobacteriaceae
12%
Acinetobacter
12%
Methicillin Resistant Staphylococcus Aureus
12%
Population
12%
Vancomycin Resistant Enterococcus
12%
Healthcare Associated Infection
12%
Pleura Effusion
12%
Ascites
12%
Influenza A
11%
Influenza Vaccine
11%
Child
11%
Inpatient
11%
Lactam
11%
Miliary Tuberculosis
10%
Age
9%
Immunology and Microbiology
Influenza
50%
Antimicrobial Resistance
50%
Gene
34%
Lineages
30%
Sample
28%
Cladistics
28%
Listeriosis
25%
Verotoxin-Producing Escherichia Coli
25%
Ciclesonide
25%
Vaccine Efficacy
24%
Plant
21%
Influenza A Virus (H3N2)
19%
Listeria monocytogenes
18%
Bacterium
18%
COVID-19
16%
Inflammatory Arthritis
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Prevalence
15%
Antibiotic-Resistant Bacteria
13%
Population
12%
Methicillin-Resistant Staphylococcus Aureus
12%
Vancomycin-Resistant Enterococcus
12%
Enterobacteriaceae
12%
Acinetobacter
12%
Pseudomonas aeruginosa
12%
Whole Genome Sequencing
11%
Rapid Influenza Diagnostic Test
10%
Serotype
9%
Exercise
8%
Drug Dose Reduction
8%
Disease-Modifying Antirheumatic Drug
8%
Viral Shedding
8%
Virus
8%
Age
7%
Virulence
7%
Mycobacterium Tuberculosis
7%
Sputum
7%
Species
6%
Normal Human
6%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
6%
Attention
6%
Spectrum
6%
Lung
5%
Dose
5%
Health
5%
Influenza A Virus (H1N1)
5%
Biofilm
5%
Central Nervous System
5%
Bacillus Anthracis
5%
Bacillus Cereus
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotic Resistance
29%
Macrolide
28%
Tuberculosis
25%
Lung Disease
25%
Haemophilus influenzae
25%
Chemotherapy
25%
Influenza A
22%
Vaccine
21%
Plant
21%
Clarithromycin
20%
Influenza
19%
Bacterium
18%
Live Attenuated Influenza Vaccine
18%
Antimicrobial Resistance
18%
Antiinfective Agent
18%
Azithromycin
17%
Adverse Event
17%
Infection
16%
Influenza A Virus (H3N2)
16%
Mycobacterium Avium Complex
15%
Prevalence
15%
Antibiotic Agent
15%
Etoposide
13%
Antibiotic-Resistant Bacteria
13%
Corticosteroid
13%
Influenza B
12%
Pseudomonas aeruginosa
12%
Enterobacteriaceae
12%
Vancomycin-Resistant Enterococcus
12%
Methicillin-Resistant Staphylococcus Aureus
12%
Acinetobacter
12%
Bloodstream Infection
12%
Carbapenem
12%
Lactam
11%
Paradoxical Reaction
10%
Miliary Tuberculosis
10%
Virus
8%
Upper Respiratory Tract Infection
8%
Respiratory Tract Infection
8%
Sepsis
7%
Mycobacterium Tuberculosis
7%
Adult Respiratory Distress Syndrome
6%
Clinical Trial
6%
Clinical Feature
6%
Extended Spectrum Beta Lactamase
6%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
6%
Normal Human
6%
Penicillinase
6%
Steroids
6%
Respiratory Failure
5%
